Novel Biologic gets a narrow victory to prevent the spread of chronic obstructive pulmonary disease

(MedPage Today)-The antibodies to the anti-ST2 exacerbated chronic pulmonary pulmonary disease (COPD) in the IIB alietho stage experience. The biological dose every two weeks reduces exacerbation of mild or severe chronic obstructive disease …